Rejlekova K - Search Results

1

Factors Associated With Choriocarcinoma Syndrome Development in Poor-Risk Patients With Germ Cell Tumors.

Rejlekova K, Kalavska K, Makovnik M, Hapakova N, Chovanec M, De Angelis V, Obertova J, Palacka P, Sycova-Mila Z, Mardiak J, Mego M. Rejlekova K, et al. Front Oncol. 2022 Jun 17;12:911879. doi: 10.3389/fonc.2022.911879. eCollection 2022. Front Oncol. 2022. PMID: 35795064 Free PMC article.

2

Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report.

Mego M, Sycova-Mila Z, Rejlekova K, Rychly B, Obertova J, Rajec J, Hes O, Mardiak J. Mego M, et al. Among authors: rejlekova k. Ann Oncol. 2008 Sep;19(9):1655-6. doi: 10.1093/annonc/mdn408. Epub 2008 Jul 8. Ann Oncol. 2008. PMID: 18611864 Free article. No abstract available.

3

Prognostic factors in patients with relapsed or primary refractory germ cell tumors.

Rejlekova K, Mego M, Sycova-Mila Z, Obertova J, Rajec J, Salek T, Mardiak J. Rejlekova K, et al. Neoplasma. 2009;56(3):215-23. doi: 10.4149/neo_2009_03_215. Neoplasma. 2009. PMID: 19309224

4

A rare case of malignant extragonadal germ cell tumor in the pineal region with an aggressive behaviour.

Rejlekova K, Mego M, Rajec J, Sycova-Mila Z, Obertova J, Mardiak J. Rejlekova K, et al. Bratisl Lek Listy. 2009;110(5):296-7. Bratisl Lek Listy. 2009. PMID: 19507665

5

Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.

Mego M, Rejlekova K, Reckova M, Sycova-Mila Z, Obertova J, Rajec J, Mardiak J. Mego M, et al. Among authors: rejlekova k. Neoplasma. 2009;56(5):398-403. doi: 10.4149/neo_2009_05_398. Neoplasma. 2009. PMID: 19580341

6

Small-cell carcinoma of the ovary with breast metastases: a case report.

Reckova M, Mego M, Rejlekova K, Sycova-Mila Z, Obertova Z, Mardiak J. Reckova M, et al. Among authors: rejlekova k. Klin Onkol. 2010;23(1):43-5. Klin Onkol. 2010. PMID: 20192073

7

Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.

Cierna Z, Mego M, Miskovska V, Machalekova K, Chovanec M, Svetlovska D, Hainova K, Rejlekova K, Macak D, Spanik S, Ondrus D, Kajo K, Mardiak J, Babal P. Cierna Z, et al. Among authors: rejlekova k. Ann Oncol. 2016 Feb;27(2):300-5. doi: 10.1093/annonc/mdv574. Epub 2015 Nov 23. Ann Oncol. 2016. PMID: 26598537 Free PMC article.

8

Phase II study of everolimus in refractory testicular germ cell tumors.

Mego M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Chovanec M, Rejlekova K, Zuzák P, Ondrus D, Spanik S, Reckova M, Mardiak J. Mego M, et al. Among authors: rejlekova k. Urol Oncol. 2016 Mar;34(3):122.e17-22. doi: 10.1016/j.urolonc.2015.10.010. Epub 2015 Nov 21. Urol Oncol. 2016. PMID: 26612480 Clinical Trial.

9

Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ.

Cierna Z, Mego M, Jurisica I, Machalekova K, Chovanec M, Miskovska V, Svetlovska D, Kalavska K, Rejlekova K, Kajo K, Mardiak J, Babal P. Cierna Z, et al. Among authors: rejlekova k. BMC Cancer. 2016 Aug 4;16:597. doi: 10.1186/s12885-016-2644-z. BMC Cancer. 2016. PMID: 27487789 Free PMC article.

10

The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.

Sestakova Z, Kalavska K, Hurbanova L, Jurkovicova D, Gursky J, Chovanec M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Cingelova S, Spanik S, Mardiak J, Chovanec M, Mego M. Sestakova Z, et al. Among authors: rejlekova k. Oncotarget. 2016 Nov 15;7(46):75996-76005. doi: 10.18632/oncotarget.12515. Oncotarget. 2016. PMID: 27732956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page